Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. I. Kurth, K. Darwiche, J. I. Baumbach, L. Freitag (Essen, Saarbruecken, Germany). A new possibility of process monitoring in lung cancer: Volatile organic compounds detected with ion mobility spectrometry to follow the success of the therapeutic process. Eur Respir J 2011; 38: Suppl. 55, 2788

Member's Comments

No comment yet.

Related content which might interest you: A step towards easier diagnosis of lung cancer: Detection of volatile organic compounds in air releasing tumour samples with ion- and differential mobility spectrometry Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer Year: 2011 Interpretation of exhaled volatile organic compounds Source: Eur Respir Monogr 2010; 49: 115-129 Year: 2010 Investigating the reproducibility of real time breath measurements using proton transfer reaction - time of flight - mass spectrometry for breath of volatile organic compounds in COPD Patients. Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018 Volatile organic compounds may provide a new and promising tool for diagnosing interstitial lung diseases Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Differential ion mobility spectrometry (DMS) for use in non invasive diagnostic from exhaled air Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Source: International Congress 2015 – The next generation of lung function tests Year: 2015 Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Ion mobility spectrometry in medical diagnostics: proof of inflammation markers in different parliamentary groups of the exhaled breath Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008 Comprehensive analysis of volatile organic compounds in human breath gas samples Source: Eur Respir J 2003; 22: Suppl. 45, 131s Year: 2003 Multiple detectable exhaled volatile organic compounds (vocs) may serve as potential inflammatory biomarkers in COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Detection of lung cancer using ion mobility spectrometry in Japan: A pilot study Source: Annual Congress 2012 - Early detection of lung cancer Year: 2012 New contributions in the determination of volatile organic compounds (VOC) in lung cancer (LC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Detection of differences in volatile organic compounds (VOCs) by ion mobility spectrometry (IMS) of exhaled breath in patients with interstitial lung diseases (ILDs) compared to healthy controls (HC) Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Novel non invasive early detection of lung cancer using liquid immunobiopsy metabolic activity profiles. Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018 Refining the breath fingerprint of mesothelioma patients by in vitro identification of cancer cell line-specific volatile metabolites Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 Ion mobility spectrometry – a new method in the diagnostic approach to sarcoidosis? Preliminary data Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006